506 related articles for article (PubMed ID: 35008730)
1. Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression.
Won E; Na KS; Kim YK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008730
[TBL] [Abstract][Full Text] [Related]
2. The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder.
Kim YK; Won E
Behav Brain Res; 2017 Jun; 329():6-11. PubMed ID: 28442354
[TBL] [Abstract][Full Text] [Related]
3. Inflammation in the brain and periphery found in animal models of depression and its behavioral relevance.
Kitaoka S
J Pharmacol Sci; 2022 Feb; 148(2):262-266. PubMed ID: 35063142
[TBL] [Abstract][Full Text] [Related]
4. Is there neuroinflammation in depression? Understanding the link between the brain and the peripheral immune system in depression.
Nettis MA; Pariante CM
Int Rev Neurobiol; 2020; 152():23-40. PubMed ID: 32450998
[TBL] [Abstract][Full Text] [Related]
5. Melatonin and Depression: A Translational Perspective From Animal Models to Clinical Studies.
Tonon AC; Pilz LK; Markus RP; Hidalgo MP; Elisabetsky E
Front Psychiatry; 2021; 12():638981. PubMed ID: 33897495
[TBL] [Abstract][Full Text] [Related]
6. Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities.
Manosso LM; Duarte LA; Martinello NS; Mathia GB; Réus GZ
CNS Neurol Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37885113
[TBL] [Abstract][Full Text] [Related]
7. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities.
Réus GZ; Manosso LM; Quevedo J; Carvalho AF
Neurosci Biobehav Rev; 2023 Dec; 155():105425. PubMed ID: 37852343
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Process and Immune System in Major Depressive Disorder.
Ruiz NAL; Del Ángel DS; Brizuela NO; Peraza AV; Olguín HJ; Soto MP; Guzmán DC
Int J Neuropsychopharmacol; 2022 Jan; 25(1):46-53. PubMed ID: 34724041
[TBL] [Abstract][Full Text] [Related]
9. Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation.
Ali T; Rahman SU; Hao Q; Li W; Liu Z; Ali Shah F; Murtaza I; Zhang Z; Yang X; Liu G; Li S
J Pineal Res; 2020 Sep; 69(2):e12667. PubMed ID: 32375205
[TBL] [Abstract][Full Text] [Related]
10. Physical Exercise and Neuroinflammation in Major Depressive Disorder.
Ignácio ZM; da Silva RS; Plissari ME; Quevedo J; Réus GZ
Mol Neurobiol; 2019 Dec; 56(12):8323-8335. PubMed ID: 31228000
[TBL] [Abstract][Full Text] [Related]
11. Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression.
Tayab MA; Islam MN; Chowdhury KAA; Tasnim FM
Biomed Pharmacother; 2022 Mar; 147():112668. PubMed ID: 35104696
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice.
Taniguti EH; Ferreira YS; Stupp IJV; Fraga-Junior EB; Mendonça CB; Rossi FL; Ynoue HN; Doneda DL; Lopes L; Lima E; Buss ZS; Vandresen-Filho S
Physiol Behav; 2018 May; 188():270-275. PubMed ID: 29458118
[TBL] [Abstract][Full Text] [Related]
13. The interaction between autophagy and neuroinflammation in major depressive disorder: From pathophysiology to therapeutic implications.
Tang M; Liu T; Jiang P; Dang R
Pharmacol Res; 2021 Jun; 168():105586. PubMed ID: 33812005
[TBL] [Abstract][Full Text] [Related]
14. Introduction to Special Issue: Brain Immunity and Neuroinflammation.
Huang L; Zhang JH
Exp Neurol; 2022 Mar; 349():113957. PubMed ID: 34974388
[No Abstract] [Full Text] [Related]
15. Neurogenic hypothesis of positive psychology in stress-induced depression: Adult hippocampal neurogenesis, neuroinflammation, and stress resilience.
Wu Z; Xiao L; Wang H; Wang G
Int Immunopharmacol; 2021 Aug; 97():107653. PubMed ID: 33915495
[TBL] [Abstract][Full Text] [Related]
16. Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder.
Bumb JM; Enning F; Mueller JK; van der List T; Rohleder C; Findeisen P; Noelte I; Schwarz E; Leweke FM
Compr Psychiatry; 2016 Jul; 68():34-9. PubMed ID: 27234180
[TBL] [Abstract][Full Text] [Related]
17. Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression.
Valdés-Tovar M; Estrada-Reyes R; Solís-Chagoyán H; Argueta J; Dorantes-Barrón AM; Quero-Chávez D; Cruz-Garduño R; Cercós MG; Trueta C; Oikawa-Sala J; Dubocovich ML; Benítez-King G
Br J Pharmacol; 2018 Aug; 175(16):3200-3208. PubMed ID: 29512136
[TBL] [Abstract][Full Text] [Related]
18. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
Wu YH; Ursinus J; Zhou JN; Scheer FA; Ai-Min B; Jockers R; van Heerikhuize J; Swaab DF
J Affect Disord; 2013 Jun; 148(2-3):357-67. PubMed ID: 23357659
[TBL] [Abstract][Full Text] [Related]
19. Mood disorders, circadian rhythms, melatonin and melatonin agonists.
Quera Salva MA; Hartley S
J Cent Nerv Syst Dis; 2012; 4():15-26. PubMed ID: 23650464
[TBL] [Abstract][Full Text] [Related]
20. Melatonin Act as an Antidepressant via Attenuation of Neuroinflammation by Targeting Sirt1/Nrf2/HO-1 Signaling.
Ali T; Hao Q; Ullah N; Rahman SU; Shah FA; He K; Zheng C; Li W; Murtaza I; Li Y; Jiang Y; Tan Z; Li S
Front Mol Neurosci; 2020; 13():96. PubMed ID: 32595452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
